Improving Insulin Sensitivity by Non-invasive Brain Stimulation
1 other identifier
interventional
44
1 country
1
Brief Summary
Efforts in curing and preventing obesity and type 2 diabetes (T2D) have been elusive thus far. One reason for that is the lack of understanding of the role of the brain in the development and treatment of the disease. In recent studies, the hypothalamus was identified as part of a brain network including higher cognitive regions that is particularly vulnerable to insulin resistance. Furthermore, the central insulin response in this network predicted food craving and hunger. In this project, transcranial direct current stimulation (tDCS) is implemented as a tool to stimulate brain networks. The investigators hypothesize that stimulating the hypothalamus-cognitive network will enhance insulin sensitivity and reduce food intake, food craving and hunger. Furthermore, the project will provide the unique opportunity to investigate novel mechanisms of insulin resistance in participants who have been extensively metabolically characterized.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2020
CompletedStudy Start
First participant enrolled
May 26, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2023
CompletedNovember 14, 2023
September 1, 2023
3.4 years
May 26, 2020
November 10, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Peripheral insulin sensitivity
Oral glucose tolerance derived insulin sensitivity based on the Matsuda index
1 day after last intervention tDCS day
Caloric intake (kcal)
Free-choice, ad libitum food intake from a standardized breakfast buffet. The caloric intake from fat, carbohydrates and protein will be documented.
1 hour directly after tDCS stimulation
Change in subjective feeling of hunger and food craving
On a visual analogue scale, subjective feeling of hunger and food craving will be assessed using a questionnaire.
5 minutes before tDCS stimulation, 5 minutes after tDCS stimulation and 5 minutes after buffet
Secondary Outcomes (5)
Performance during stop-signal task
task is performed during 25-minutes tDCS stimulation
Tastiness and healthiness rating of food stimuli
task is performed immediatly after buffet
Food choice
task is performed immediatly after buffet
Functional connectivity
10 minutes functional MRI measurement performed before and after three day tDCS stimulation
Diffusion-weighted imaging
15 minutes MRI measurement performed before and after three day tDCS stimulation
Study Arms (3)
Anodal tDCS
ACTIVE COMPARATORAnodal tDCS of the hypothalamus-cognitive network
Cathodal tDCS
ACTIVE COMPARATORCathodal tDCS of the hypothalamus-cognitive network
Sham Stimulation
SHAM COMPARATORDouble blind sham stimulation (ramp-up ramp-down stimulation will be applied in order to simulate the active condition without any further continuous administration of current)
Interventions
anodal or cathodal transcranial direct current stimulation
Eligibility Criteria
You may qualify if:
- Body mass index (BMI) between 25.5 and 39.5 kg/m2
- Age between 20 to 66 years of age
- Waist circumference ≥ 80 cm for women, ≥ 94 cm for men
You may not qualify if:
- Insufficient knowledge of the German language
- Persons who cannot legally give consent
- Pregnancy or lactation
- History of severe mental or somatic disorders including neurological diseases (incl. epileptic seizures)
- Taking psychotropic drugs
- Previous bariatric surgery
- Acute infection within the last 4 weeks
- Hemoglobin values less than 12g/dl for women, less than 14 g/dl for men
- Current participation in a lifestyle intervention study or a pharmaceutical study
- Contradictions to a MRI measurement (e.g. metal implants)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Tuebingenlead
- German Center for Diabetes Researchcollaborator
Study Sites (1)
University Clinic Tübingen
Tübingen, 72076, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephanie Kullmann, PhD
Univeristy of Tübingen, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2020
First Posted
June 9, 2020
Study Start
May 26, 2020
Primary Completion
October 31, 2023
Study Completion
November 10, 2023
Last Updated
November 14, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share